CLINICAL_TRIALS
trial_result
· 2023-03-03
Clinical Trial Update: Radiation and Combination Immunotherapy for Melanoma [Phase 2]
Summary
Phase 2 trial evaluating the combination of radiation therapy and immunotherapy for metastatic melanoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2023-03-03